Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics symbols : Ms save search
TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional Shares
Published: 2024-04-24 (Crawled : 15:00) - globenewswire.com
TCRX | News 3 d | $7.39 1.79% 1.76% 91K
|
Professional, Scientific, and T...
|
| O: -0.21%
H: 0.0%
C: 0.0%
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: -0.59%
H: 0.0%
C: 0.0%
therapeutics
TScan Therapeutics Announces Closing of Upsized Public Offering
Published: 2024-04-19 (Crawled : 14:00) - globenewswire.com
TCRX | News 3 d | $7.39 1.79% 1.76% 91K
|
Professional, Scientific, and T...
|
| O: 1.04%
H: 4.55%
C: 0.0%
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: -0.13%
H: 0.0%
C: 0.0%
offering therapeutics
TScan Therapeutics Announces Pricing of Upsized $150 Million Public Offering
Published: 2024-04-17 (Crawled : 05:00) - globenewswire.com
TCRX | News 3 d | $7.39 1.79% 1.76% 91K
|
Professional, Scientific, and T...
|
| O: -2.15%
H: 1.24%
C: -7.15%
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: -0.14%
H: 0.0%
C: 0.0%
million offering therapeutics
TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering
Published: 2024-04-16 (Crawled : 20:00) - globenewswire.com
TCRX | News 3 d | $7.39 1.79% 1.76% 91K
|
Professional, Scientific, and T...
|
| O: -2.15%
H: 1.24%
C: -7.15%
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: -0.14%
H: 0.0%
C: 0.0%
million offering therapeutics
Cullinan Therapeutics Announces Oversubscribed $280 million Private Placement
Published: 2024-04-16 (Crawled : 11:00) - globenewswire.com
CGEM | $18.9 13.38% 11.8% 1.2M
|
|
| O: 15.52%
H: 3.77%
C: -12.83%
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: 2.98%
H: 0.0%
C: 0.0%
million therapeutics
Contineum Therapeutics Announces Pricing of Initial Public Offering - April 05, 2024
Published: 2024-04-05 (Crawled : 09:00) - biospace.com/
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: -2.11%
H: 0.0%
C: 0.0%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.84%
H: 0.0%
C: 0.0%
offering therapeutics
Contineum Therapeutics Announces Pricing of Initial Public Offering
Published: 2024-04-05 (Crawled : 01:00) - globenewswire.com
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: -2.11%
H: 0.0%
C: 0.0%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.84%
H: 0.0%
C: 0.0%
offering therapeutics
Pharmaceutical and Biotechnology Royalty Rates Report 2024: Essential Benchmark Data for Dealmakers - Royalty Rates, Deal Financials, Contract Documents, Royalty Rate Trends
Published: 2024-03-14 (Crawled : 00:00) - prnewswire.com
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: -0.39%
H: 0.45%
C: 0.11%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -0.51%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
NKTR | News | $1.39 -2.11% -2.16% 960K
|
Health Technology
|
| O: 2.35%
H: 2.3%
C: -1.15%
IMAB | $1.805 0.28% 0.28% 110K
|
Health Technology
|
| O: -1.63%
H: 0.55%
C: -0.55%
report contract royalty trends deal
Akero Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
Published: 2024-03-08 (Crawled : 21:00) - globenewswire.com
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
| Email alert
Add to watchlist
AKRO | $20.23 -3.67% -3.81% 580K
|
Health Technology
| Email alert
Add to watchlist
offering therapeutics
Akero Therapeutics Announces Pricing of Public Offering of Common Stock - March 06, 2024
Published: 2024-03-06 (Crawled : 12:00) - biospace.com/
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: -2.65%
H: 1.36%
C: -1.28%
AKRO | $20.23 -3.67% -3.81% 580K
|
Health Technology
|
| O: 2.23%
H: 3.85%
C: -3.85%
offering therapeutics
Akero Therapeutics Announces Pricing of Public Offering of Common Stock
Published: 2024-03-06 (Crawled : 03:00) - globenewswire.com
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: -2.65%
H: 1.36%
C: -1.28%
AKRO | $20.23 -3.67% -3.81% 580K
|
Health Technology
|
| O: 2.23%
H: 3.85%
C: -3.85%
offering therapeutics
Viking Therapeutics Announces Closing of Public Offering of Common Stock Including Full Exercise of Underwriters' Option to Purchase Additional Shares
Published: 2024-03-04 (Crawled : 22:00) - prnewswire.com
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: -0.94%
H: 2.19%
C: -0.07%
VKTX | $65.03 0.15% 0.15% 2.6M
|
Health Technology
|
| O: -1.47%
H: 3.24%
C: -2.33%
LGND | $70.87 1.4% 1.38% 150K
|
Health Technology
|
| O: -0.75%
H: 1.55%
C: -2.26%
offering therapeutics
Akero Therapeutics Announces Proposed Public Offering of Common Stock
Published: 2024-03-04 (Crawled : 21:00) - globenewswire.com
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: -0.94%
H: 2.19%
C: -0.07%
AKRO | $20.23 -3.67% -3.81% 580K
|
Health Technology
|
| O: -1.03%
H: 1.95%
C: -0.75%
offering therapeutics
Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock
Published: 2024-02-29 (Crawled : 02:00) - prnewswire.com
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: 0.51%
H: 0.17%
C: -0.52%
VKTX | $65.03 0.15% 0.15% 2.6M
|
Health Technology
|
| O: -4.5%
H: 3.38%
C: -14.63%
LGND | $70.87 1.4% 1.38% 150K
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: -6.71%
million offering therapeutics
Kyverna Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Published: 2024-02-12 (Crawled : 22:00) - prnewswire.com
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: -1.16%
H: 0.0%
C: -2.2%
offering therapeutics
Kyverna Therapeutics Announces Pricing of Upsized Initial Public Offering
Published: 2024-02-08 (Crawled : 04:00) - prnewswire.com
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: -0.37%
H: 0.64%
C: -0.04%
offering therapeutics
Silence Therapeutics Announces Oversubscribed $120 Million Private Placement
Published: 2024-02-05 (Crawled : 14:00) - biospace.com/
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: -0.79%
H: 0.0%
C: -0.8%
SLN | $22.33 -0.8% -0.81% 110K
|
Health Technology
|
| O: 1.44%
H: 1.28%
C: -5.22%
million therapeutics
Bristol Myers Squibb Completes Acquisition of Mirati Therapeutics, Strengthening and Diversifying Oncology Portfolio
Published: 2024-01-23 (Crawled : 14:30) - biospace.com/
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: -0.07%
H: 1.38%
C: 1.25%
EVR | $186.59 -4.85% 0.0% 1.3M
|
Finance
|
| O: 0.35%
H: 0.29%
C: -0.26%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.22%
H: 1.49%
C: 0.89%
acquisition
Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
Published: 2024-01-11 (Crawled : 21:00) - globenewswire.com
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: 0.85%
H: 0.67%
C: -1.73%
DYN | $24.98 -1.81% -1.84% 680K
|
Health Technology
|
| O: 4.08%
H: 3.59%
C: -2.28%
offering therapeutics
Kymera Therapeutics Announces Closing of Upsized $275 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Published: 2024-01-09 (Crawled : 14:00) - globenewswire.com
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: -0.81%
H: 0.09%
C: -0.74%
KYMR | $35.18 -1.48% -1.51% 380K
|
Health Technology
|
| O: -1.44%
H: 10.79%
C: 9.37%
million offering therapeutics
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.